Published in JAMA Otolaryngol Head Neck Surg on May 01, 2013
Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature. Oncotarget (2015) 0.93
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma. J Clin Invest (2015) 0.90
Significance of the Extracapsular Spread of Metastatic Lymph Nodes in Papillary Thyroid Carcinoma. Clin Exp Otorhinolaryngol (2015) 0.85
Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma. Eur Arch Otorhinolaryngol (2013) 0.76
Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma. Medicine (Baltimore) (2016) 0.76
Genomic sequencing and precision medicine in head and neck cancers. Eur J Surg Oncol (2016) 0.75
Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas. Oncotarget (2016) 0.75
Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2016) 0.75
Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma. Front Oncol (2017) 0.75
Prognostic significance of extracapsular spread in isolated neck recurrences in head and neck squamous cell carcinoma patients. Eur Arch Otorhinolaryngol (2016) 0.75
Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol (2007) 2.30
Second, third, and fourth head and neck tumors. A progressive decrease in survival. Head Neck (2012) 1.97
The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer (2004) 1.63
Lymphadenopathy caused by Mycobacterium colombiense. J Clin Microbiol (2008) 1.20
[Diagnosis and treatment of nocturnal paroxysmal hemoglobinuria]. Med Clin (Barc) (2010) 1.10
Hypothyroidism in patients treated with total laryngectomy. A multivariate study. Eur Arch Otorhinolaryngol (2002) 1.02
Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2. J Lipid Res (2012) 1.01
Variability in nerve patterns of the adductor muscle group supplied by the recurrent laryngeal nerve. Laryngoscope (2005) 0.99
Structural insights into the activation mechanism of melibiose permease by sodium binding. Proc Natl Acad Sci U S A (2010) 0.99
Is the external laryngeal nerve an exclusively motor nerve? The cricothyroid connection branch. Laryngoscope (2003) 0.96
The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy. Radiother Oncol (2003) 0.94
Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study. Cancer Causes Control (2008) 0.94
Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer. Int J Cancer (2008) 0.93
Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation. Microvasc Res (2011) 0.92
Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol (2005) 0.90
Assessing glomerular filtration rate in hospitalized patients: a comparison between CKD-EPI and four cystatin C-based equations. Clin J Am Soc Nephrol (2011) 0.90
Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma. Head Neck (2005) 0.90
Prostaglandin E(2) pathway in head and neck squamous cell carcinoma. Head Neck (2008) 0.89
Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society. Eur Arch Otorhinolaryngol (2009) 0.89
Supracricoid laryngectomy as salvage surgery after failure of radiation therapy. Eur Arch Otorhinolaryngol (2007) 0.83
Incidence and significance of clinically unsuspected thyroid tissue in lymph nodes found during neck dissection in head and neck carcinoma patients. Laryngoscope (2005) 0.83
Variability of the nerve supply patterns of the human posterior cricoarytenoid muscle. Laryngoscope (2003) 0.83
European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol (2014) 0.83
High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma. Cancer Med (2013) 0.82
Parotidectomies in benign parotid tumours: "Sant Pau" surgical extension classification. Acta Otorrinolaringol Esp (2009) 0.82
Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy. J Pathol (2015) 0.81
Risk of third and fourth tumors in patients with head and neck cancer. Head Neck (2010) 0.81
Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy. Head Neck (2012) 0.81
Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathway. J Clin Endocrinol Metab (2013) 0.80
Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy. Oral Oncol (2012) 0.80
Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation. Diagn Mol Pathol (2005) 0.80
In-plane and out-of-plane infrared difference spectroscopy unravels tilting of helices and structural changes in a membrane protein upon substrate binding. J Am Chem Soc (2009) 0.80
Potential structures that could be confused with a nonrecurrent inferior laryngeal nerve: an anatomic study. Laryngoscope (2008) 0.79
Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma. Eur Arch Otorhinolaryngol (2004) 0.79
Prognostic factors in head and neck squamous cell carcinoma: comparison of CHAID decision trees technology and Cox analysis. Head Neck (2012) 0.78
Reconstruction of a perianal defect by means of a bilateral V-Y advancement flap based on the perforating arteries of the gluteus maximus shaped over a cicatricial area. J Plast Reconstr Aesthet Surg (2008) 0.78
[Two cases of intraparotid facial nerve schwannoma]. Acta Otorrinolaringol Esp (2010) 0.78
[Diagnosis and treatment of functional oropharyngeal dysphagia. Features of interest to the digestive surgeon]. Cir Esp (2007) 0.78
Development and (pre-) clinical assessment of a novel surgical tool for primary and secondary tracheoesophageal puncture with immediate voice prosthesis insertion, the Provox Vega Puncture Set. Eur Arch Otorhinolaryngol (2012) 0.78
[A prospective, multicentre study on the activity of general and digestive surgery residents based on the use of the computerised logbook]. Cir Esp (2012) 0.77
Studying substrate binding to reconstituted secondary transporters by attenuated total reflection infrared difference spectroscopy. Methods Mol Biol (2012) 0.77
Ceratocricoid muscle: an embryological and anatomical study. Clin Anat (2009) 0.77
Comparison of chi-squared automatic interaction detection classification trees vs TNM classification for patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2012) 0.77
Total or subtotal glossectomy with microsurgical reconstruction: functional and oncological results. Microsurgery (2011) 0.76
Laryngeal cancer in non-smoking and non-drinking patients. Acta Otolaryngol (2004) 0.75
Round ligament metastatic gastric cancer as a finding in an inguinal surgery. Gastrointest Cancer Res (2012) 0.75
[Larynx transplant: a therapeutic option for the 21st century? Literature review]. Acta Otorrinolaringol Esp (2008) 0.75
Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced pyriform sinus carcinoma. Eur Arch Otorhinolaryngol (2002) 0.75
Recurrent laryngeal squamous cell carcinoma: rTNM versus composite laryngeal recurrence staging system. Proposal for a modification of the CLRSS to improve patient classification. Head Neck (2008) 0.75
External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy. Head Neck (2007) 0.75
Proton-pump inhibitors in sleep-related breathing disorders: clinical response and predictive factors. Eur J Gastroenterol Hepatol (2011) 0.75
Elective treatment of the neck for second primary tumors of the head and neck. Eur Arch Otorhinolaryngol (2013) 0.75
Superficial thrombophlebitis as an exceptional complication of a scrotal arteriovenous malformation. Clin Transl Oncol (2007) 0.75
Is dissection of level V necessary in patients with T(2)-T(4)N(0) supraglottic cancer? J Laryngol Otol (2004) 0.75
[Results of an organ conservation protocol in patients with locally advanced laryngeal tumours]. Acta Otorrinolaringol Esp (2009) 0.75
[Organ preservation in laryngeal and hypopharyngeal cancer]. Acta Otorrinolaringol Esp (2007) 0.75